{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:00:06Z","timestamp":1792206006982,"version":"4.4.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870551 \/ 82070844 \/ 82025008"],"award-info":[{"award-number":["81870551 \/ 82070844 \/ 82025008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7212123"],"award-info":[{"award-number":["7212123"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.metabol.2022.155292","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T21:42:55Z","timestamp":1660945375000},"page":"155292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Imipramine activates FAM3A-FOXA2-CPT2 pathway to ameliorate hepatic steatosis"],"prefix":"10.1016","volume":"136","author":[{"given":"Xiangyang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155292_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155292_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155292_bb0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/geno.2002.6816","article-title":"Cloning, expression, and initial characterization of a novel cytokine-like gene family","volume":"80","author":"Zhu","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.metabol.2022.155292_bb0020","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.26945","article-title":"FAM3A activates PI3K p110alpha\/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis","volume":"59","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155292_bb0025","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/db16-1172","article-title":"NFE2 induces miR-423-5p to promote gluconeogenesis and hyperglycemia by repressing the hepatic FAM3A-ATP-akt pathway","volume":"66","author":"Yang","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155292_bb0030","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/db19-1038","article-title":"Repurposing doxepin to ameliorate steatosis and hyperglycemia by activating FAM3A signaling pathway","volume":"69","author":"Chen","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155292_bb0035","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1096\/fj.201902368RR","article-title":"FAM3A plays crucial roles in controlling PDX1 and insulin expressions in pancreatic beta cells","volume":"34","author":"Yang","year":"2020","journal-title":"FASEB J"},{"issue":"8","key":"10.1016\/j.metabol.2022.155292_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1055\/a-1608-0607","article-title":"Intracellular ATP signaling contributes to FAM3A-induced PDX1 upregulation in pancreatic Beta cells","volume":"130","author":"Yan","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.metabol.2022.155292_bb0045","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yjmcc.2014.05.011","article-title":"FAM3A promotes vascular smooth muscle cell proliferation and migration and exacerbates neointima formation in rat artery after balloon injury","volume":"74","author":"Jia","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.metabol.2022.155292_bb0050","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/CIRCRESAHA.119.315558","article-title":"VSMC-specific deletion of FAM3A attenuated ang II-promoted hypertension and cardiovascular hypertrophy","volume":"126","author":"Xiang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2022.155292_bb0055","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1016\/j.bbagen.2013.03.029","article-title":"FAM3A is a target gene of peroxisome proliferator-activated receptor gamma","volume":"1830","author":"Zhou","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2022.155292_bb0060","doi-asserted-by":"crossref","first-page":"45862","DOI":"10.18632\/oncotarget.17578","article-title":"FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-akt signaling pathway","volume":"8","author":"Chi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2022.155292_bb0065","doi-asserted-by":"crossref","first-page":"49882","DOI":"10.18632\/oncotarget.17805","article-title":"FAM3A mediates PPARgamma's protection in liver ischemia-reperfusion injury by activating akt survival pathway and repressing inflammation and oxidative stress","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.metabol.2022.155292_bb0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuint.2016.02.010","article-title":"FAM3A attenuates ER stress-induced mitochondrial dysfunction and apoptosis via CHOP-wnt pathway","volume":"94","author":"Song","year":"2016","journal-title":"Neurochem Int"},{"key":"10.1016\/j.metabol.2022.155292_bb0075","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1159\/000485943","article-title":"FAM3A protects against glutamate-induced toxicity by preserving calcium homeostasis in differentiated PC12 cells","volume":"44","author":"Song","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.metabol.2022.155292_bb0080","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1159\/000438512","article-title":"FAM3A protects HT22 cells against hydrogen peroxide-induced oxidative stress through activation of PI3K\/Akt but not MEK\/ERK pathway","volume":"37","author":"Song","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.metabol.2022.155292_bb0085","article-title":"FAM3A ameliorates brain impairment induced by hypoxia-ischemia in neonatal rat","author":"Song","year":"2021","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.metabol.2022.155292_bb0090","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2337\/dc07-2215","article-title":"Effect of race\/ethnicity and persistent recognition of depression on mortality in elderly men with type 2 diabetes and depression","volume":"31","author":"Richardson","year":"2008","journal-title":"Diabetes Care"},{"issue":"Suppl","key":"10.1016\/j.metabol.2022.155292_bb0095","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0165-0327(12)70008-3","article-title":"Economic aspects of the association between diabetes and depression: a systematic review","volume":"142","author":"Molosankwe","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.metabol.2022.155292_bb0100","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/liv.12165","article-title":"Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease","volume":"33","author":"Youssef","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2022.155292_bb0105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2213-8587(15)00045-5","article-title":"Depression and diabetes: treatment and health-care delivery","volume":"3","author":"Petrak","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2022.155292_bb0110","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.psy.0000221276.17823.df","article-title":"Depression, anxiety, and nonalcoholic steatohepatitis","volume":"68","author":"Elwing","year":"2006","journal-title":"Psychosom Med"},{"key":"10.1016\/j.metabol.2022.155292_bb0115","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/appi.ajp.2008.08071065","article-title":"Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus","volume":"166","author":"Andersohn","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.metabol.2022.155292_bb0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/01.jcp.0000095341.32154.8f","article-title":"African women with depression: the effect of imipramine and fluoxetine on body mass index and leptin secretion","volume":"23","author":"Moosa","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.metabol.2022.155292_bb0125","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0165-1781(92)90017-W","article-title":"Imipramine effect on hypothalamic-pituitary-adrenal axis response to hypoglycemia","volume":"41","author":"Kathol","year":"1992","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.metabol.2022.155292_bb0130","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1007\/s11064-015-1670-6","article-title":"Effect of imipramine, paroxetine, and lithium carbonate on neurobehavioral changes of streptozotocin in rats: impact on glycogen synthase Kinase-3 and blood glucose level","volume":"40","author":"Nadeem","year":"2015","journal-title":"Neurochem Res"},{"key":"10.1016\/j.metabol.2022.155292_bb0135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155292_bb0140","first-page":"65","article-title":"Effect of acute & chronic imipramine treatment on glucose homeostasis","volume":"96","author":"Gupta","year":"1992","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.metabol.2022.155292_bb0145","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.jcp.0000186737.76653.57","article-title":"Impaired glucose homeostasis after imipramine intake in a diabetic patient","volume":"25","author":"Derijks","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.metabol.2022.155292_bb0150","first-page":"1509","article-title":"Hypoglycemia associated with imipramine","volume":"18","author":"Shrivastava","year":"1983","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.metabol.2022.155292_bb0155","doi-asserted-by":"crossref","first-page":"G515","DOI":"10.1152\/ajpgi.00455.2011","article-title":"Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice","volume":"302","author":"Liangpunsakul","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.metabol.2022.155292_bb0160","article-title":"Imipramine accelerates nonalcoholic fatty liver disease, renal impairment, diabetic retinopathy, insulin resistance, and urinary chromium loss in obese mice","volume":"8","author":"Chang","year":"2021","journal-title":"Vet Sci"},{"key":"10.1016\/j.metabol.2022.155292_bb0165","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejphar.2008.11.010","article-title":"Differential sensitivity to SSRI and tricyclic antidepressants in juvenile and adult mice of three strains","volume":"602","author":"Mason","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.metabol.2022.155292_bb0170","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1523\/JNEUROSCI.21-13-04875.2001","article-title":"The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety","volume":"21","author":"Schramm","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.metabol.2022.155292_bb0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ebiom.2017.09.010","article-title":"IRX3 promotes the Browning of white adipocytes and its rare variants are associated with human obesity risk","volume":"24","author":"Zou","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.metabol.2022.155292_bb0180","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/jcmm.14073","article-title":"FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes","volume":"23","author":"Chi","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2022.155292_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.109184","article-title":"Estimation of abdominal subcutaneous fat volume of obese adults from single-slice MRI data - regression coefficients and agreement","volume":"130","author":"Linder","year":"2020","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.metabol.2022.155292_bb0190","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s00261-017-1289-y","article-title":"Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors","volume":"43","author":"Joshi","year":"2018","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.metabol.2022.155292_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","article-title":"The link between depression and diabetes: the search for shared mechanisms","volume":"3","author":"Moulton","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2022.155292_bb0200","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/db14-0427","article-title":"Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch","volume":"64","author":"Xiang","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155292_bb0205","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0962-8924(00)01800-6","article-title":"Calmodulin: a prototypical calcium sensor","volume":"10","author":"Chin","year":"2000","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.metabol.2022.155292_bb0210","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0092-8674(02)00682-7","article-title":"Calmodulin in action: diversity in target recognition and activation mechanisms","volume":"108","author":"Hoeflich","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2022.155292_bb0215","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","article-title":"Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects","volume":"25","author":"Bonnefont","year":"2004","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.metabol.2022.155292_bb0220","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ajmg.c.30087","article-title":"Disorders of carnitine transport and the carnitine cycle","volume":"142C","author":"Longo","year":"2006","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"10.1016\/j.metabol.2022.155292_bb0225","first-page":"25","article-title":"Muscle carnitine palmitoyltransferase II (CPT II) deficiency: a conceptual approach","author":"Joshi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.metabol.2022.155292_bb0230","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1067\/mpd.2002.128545","article-title":"Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations","volume":"141","author":"Vladutiu","year":"2002","journal-title":"J Pediatr"},{"key":"10.1016\/j.metabol.2022.155292_bb0235","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ymgme.2008.05.002","article-title":"CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency","volume":"94","author":"Isackson","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2022.155292_bb0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ymgme.2011.05.003","article-title":"Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death","volume":"104","author":"Yahyaoui","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.metabol.2022.155292_bb0245","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.celrep.2016.05.062","article-title":"Hepatic fatty acid oxidation restrains systemic catabolism during starvation","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2022.155292_bb0250","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature03649","article-title":"The initiation of liver development is dependent on foxa transcription factors","volume":"435","author":"Lee","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155292_bb0255","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature03047","article-title":"Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes","volume":"432","author":"Wolfrum","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155292_bb0260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cmet.2013.01.014","article-title":"Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism","volume":"17","author":"von Meyenn","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2022.155292_bb0265","doi-asserted-by":"crossref","first-page":"15532","DOI":"10.1038\/s41598-017-15831-6","article-title":"FOXA2 alleviates CCl4-induced liver fibrosis by protecting hepatocytes in mice","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2022.155292_bb0270","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cmet.2006.01.001","article-title":"Coactivation of Foxa2 through pgc-1beta promotes liver fatty acid oxidation and triglyceride\/VLDL secretion","volume":"3","author":"Wolfrum","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2022.155292_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.psym.2012.09.005","article-title":"Association of chronic liver disease with depression: a population-based study","volume":"54","author":"Lee","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1016\/j.metabol.2022.155292_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2020.104705","article-title":"Antidepressant effect in diabetes-associated depression: a novel potential of RAAS inhibition","volume":"118","author":"Balogh","year":"2020","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.metabol.2022.155292_bb0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00125-011-2268-4","article-title":"Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults","volume":"55","author":"Pan","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2022.155292_bb0290","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40263-017-0436-x","article-title":"Impact of muscarinic M3 receptor antagonism on the risk of type 2 diabetes in antidepressant-treated patients: a case-controlled study","volume":"31","author":"Tran","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.metabol.2022.155292_bb0295","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/bcp.13699","article-title":"Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance-pharmacodynamic study","volume":"84","author":"Siafis","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.metabol.2022.155292_bb0300","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diabres.2007.07.009","article-title":"Type of antidepressant therapy and risk of type 2 diabetes in people with depression","volume":"79","author":"Brown","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2022.155292_bb0305","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0165-1781(88)90120-5","article-title":"Antidepressant-induced weight gain: a comparison study of four medications","volume":"26","author":"Fernstrom","year":"1988","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.metabol.2022.155292_bb0310","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/070674378803300706","article-title":"Carbohydrate craving and increased appetite associated with antidepressant therapy","volume":"33","author":"Yeragani","year":"1988","journal-title":"Can J Psychiatr Rev Can Psychiatr"},{"key":"10.1016\/j.metabol.2022.155292_bb0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0165-1781(86)90074-0","article-title":"Chronic imipramine treatment and weight gain","volume":"17","author":"Fernstrom","year":"1986","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.metabol.2022.155292_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-198409010-00001","article-title":"First-pass elimination. Basic concepts and clinical consequences","volume":"9","author":"Pond","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metabol.2022.155292_bb0325","first-page":"1329","article-title":"Oral bioavailability and first-pass effects","volume":"25","author":"Kwan","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.metabol.2022.155292_bb0330","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2165\/00003088-200342130-00005","article-title":"Clinical pharmacokinetics of atorvastatin","volume":"42","author":"Lennernas","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.metabol.2022.155292_bb0335","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2022.155292_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154228","article-title":"PINK1-PRKN mitophagy suppression by mangiferin promotes a brown-fat-phenotype via PKA-p38 MAPK signalling in murine C3H10T1\/2 mesenchymal stem cells","volume":"107","author":"Rahman","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155292_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.153955","article-title":"Adaptor protein APPL1 coordinates HDAC3 to modulate brown adipose tissue thermogenesis in mice","volume":"100","author":"Fan","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155292_bb0350","article-title":"Alternative polyadenylation and differential regulation of ucp 1: implications for Brown adipose tissue thermogenesis across species","volume":"8","author":"Lu","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.metabol.2022.155292_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154396","article-title":"UCP1-dependent and UCP1-independent metabolic changes induced by acute cold exposure in brown adipose tissue of mice","volume":"113","author":"Okamatsu-Ogura","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155292_bb0360","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/cpt1979265647","article-title":"Effect of imipramine on norepinephrine and blood pressure in enuretic boys","volume":"26","author":"Lake","year":"1979","journal-title":"Clin Pharmacol Ther"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522001706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:15:49Z","timestamp":1777425349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522001706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":72,"alternative-id":["S0026049522001706"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155292","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imipramine activates FAM3A-FOXA2-CPT2 pathway to ameliorate hepatic steatosis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155292"}}